Immuno-oncology: what have been the top advancements in 2021?
Immuno-oncology can be broadly defined as those treatments that utilize the body’s immune system to fight cancer from within. Combination therapies continue to yield encouraging results and other novel checkpoint inhibitors have led to an increasing number of possible treatments. However, there are still numerous hurdles that need to be overcome to make immuno-oncology a long-term option for more cancer types. In this article, we explore the biggest advancements that have been made in the field over the past year and what remains to be tackled. The promise of combination immunotherapies Combination therapies continue to show promise in the immuno-oncology...